Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis: Effects of antioxidant therapy with NADPH oxidase inhibition

Circulation: Cardiovascular Imaging

Volumn 6, Issue 1, 2013, Pages 74-82

  Liu, Yani ^a,c   Davidson, Brian P ^a   Yue, Qi ^a   Belcik, Todd ^a   Xie, Aris ^a   Inaba, Yoichi ^a   McCarty, Owen J T ^b   Tormoen, Garth W ^b   Zhao, Yan ^a   Ruggeri, Zaverio M ^d   Kaufmann, Beat A ^e   Lindner, Jonathan R ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Oregon Health and Science University Department of Biomedical Engineering   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Contrast ultrasound; Microbubbles; Oxidative stress; Platelets

Indexed keywords

APOCYNIN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; GLYCOPROTEIN IB ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; PADGEM PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASCULAR CELL ADHESION MOLECULE 1; ANTIOXIDANT; ENZYME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG MEGADOSE; ECHOGRAPHY; ENZYME INHIBITION; HEMODYNAMICS; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MOLECULAR IMAGING; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE WAVE; THERAPY EFFECT; THORACIC AORTA; THROMBOCYTE ADHESION; VASCULITIS; YOUNG MODULUS; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; INFLAMMATION; METHODOLOGY; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; INFLAMMATION; MICE; MICE, INBRED C57BL; MOLECULAR IMAGING; NADPH OXIDASE; PLATELET ADHESIVENESS;

MLCS; MLOWN;

EID: 84874525887     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.112.975193     Document Type: Article

References (37)

1. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005;25:29-38.
2. Lubos E, Handy DE, Loscalzo J. Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci. 2008;13:5323-5344.
3. Wolin MS. Interactions of oxidants with vascular signaling systems. Arte-rioscler Thromb Vasc Biol. 2000;20:1430-1442.
4. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999;85:753-766.
5. Freedman JE. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol. 2008;28:s11-s16.
6. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464-1476.
7. Yu J, Weïwer M, Linhardt RJ, Dordick JS. The role of the methoxyphe-nol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventa-tive agent in the potential treatment of cardiovascular diseases. Curr Vasc Pharmacol. 2008;6:204-217.
8. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest. 2001;108:1513-1522.
9. Suzuki Y, Wang W, Vu TH, Raffn TA. Effect of NADPH oxidase inhibition on endothelial cell ELAM-1 mRNA expression. Biochem Biophys Res Commun. 1992;184:1339-1343.
10. von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K, Weber C. RANTES deposition by platelets triggers monocyte arrest on in-famed and atherosclerotic endothelium. Circulation. 2001;103:1772-1777.
11. Massberg S, Brand K, Grüner S, Page S, Müller E, Müller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887-896.
12. Powell-Braxton L, Véniant M, Latvala RD, Hirano KI, Won WB, Ross J, Dybdal N, Zlot CH, Young SG, Davidson NO. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med. 1998;4:934-938.
13. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of infammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001;104:2107-2112.
14. Kaufmann BA, Carr CL, Belcik JT, Xie A, Yue Q, Chadderdon S, Caplan ES, Khangura J, Bullens S, Bunting S, Lindner JR. Molecular imaging of the initial infammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol. 2010;30:54-59.
15. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson WR Jr. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol. 1995;147:1016-1028.
16. http://rsbweb.nih.gov/ij/docs/index.html November, 2011.
17. Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, Sarembock IJ, Lindner JR. Molecular imaging of infammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007;116:276-284.
18. Tummala PE, Chen XL, Medford RM. NF-kappa B independent suppression of endothelial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 gene expression by inhibition of favin binding proteins and superoxide production. J Mol Cell Cardiol. 2000;32:1499-1508.
19. Cayatte AJ, Rupin A, Oliver-Krasinski J, Maitland K, Sansilvestri-Morel P, Boussard MF, Wierzbicki M, Verbeuren TJ, Cohen RA. S17834, a new inhibitor of cell adhesion and atherosclerosis that targets nadph oxidase. Arterioscler Thromb Vasc Biol. 2001;21:1577-1584.
20. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem. 1999;274:19814- 19822.
21. De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, Griendling KK. Tumour necrosis factor alpha activates a p22phox-based NADH oxi-dase in vascular smooth muscle. Biochem J. 1998;329(Pt 3):653-657.
22. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxi-dase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271:23317-23321.
23. Wedgwood S, Dettman RW, Black SM. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1058-L1067.
24. Weber C, Erl W, Pietsch A, Ströbel M, Ziegler-Heitbrock HW, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factorkappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb. 1994;14:1665-1673.
25. Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Bramanti P, Cuzzocrea S. Effect of apocynin, a NADPH oxidase inhibitor, on acute lung infammation. Biochem Pharmacol. 2011;81:636-648.
26. Holland JA, Johnson DK. Prevention of atherosclerosis using NADPH oxidase inhibitors. US Patent 5, 902, 831, 1999.
27. Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood. 2006;108:1903-1910.
28. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Circulating activated platelets exacerbate atherosclerosis in mice defcient in apolipoprotein E. Nat Med. 2003;9:61-67.
29. Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res. 2005;96:612-616.
30. Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, MüllerBerghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an infammatory reaction of endothelial cells. Nature. 1998;391:591-594.
31. Kuijper PH, Gallardo Torres HI, Houben LA, Lammers JW, Zwaginga JJ, Koenderman L. P-selectin and MAC-1 mediate monocyte rolling and adhesion to ECM-bound platelets under fow conditions. J Leukoc Biol. 1998;64:467-473.
32. van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol. 2009;85:195-204.
33. McCarty OJ, Conley RB, Shentu W, Tormoen GW, Zha D, Xie A, Qi Y, Zhao Y, Carr C, Belcik T, Keene DR, de Groot PG, Lindner JR. Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype. J AM COLL CARDIOL. Cardiovasc Imaging. 2010;3:947-955.
34. Patel RS, Al Mheid I, Morris AA, Ahmed Y, Kavtaradze N, Ali S, Dabhad-kar K, Brigham K, Hooper WC, Alexander RW, Jones DP, Quyyumi AA. Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis. 2011;218:90-95.
35. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Bräsen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Böhm M, Meinertz T, Münzel T. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation. 1999;99:2027-2033.
36. Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. Microbubble persistence in the microcirculation during ischemia/reper-fusion and infammation is caused by integrin-and complement-mediated adherence to activated leukocytes. Circulation. 2000;101:668-675.
37. Anderson DR, Tsutsui JM, Xie F, Radio SJ, Porter TR. The role of complement in the adherence of microbubbles to dysfunctional arterial endo-thelium and atherosclerotic plaque. Cardiovasc Res. 2007;73:597-606.